These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34844465)

  • 1. Two Cases of Severe Autoimmune Thyrotoxicosis Following SARS-CoV-2 Infection.
    Edwards K; Hussain I
    J Investig Med High Impact Case Rep; 2021; 9():23247096211056497. PubMed ID: 34844465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.
    Lui DTW; Lee KK; Lee CH; Lee ACH; Hung IFN; Tan KCB
    Front Public Health; 2021; 9():778964. PubMed ID: 34888290
    [No Abstract]   [Full Text] [Related]  

  • 3. Graves' disease after exposure to the SARS-CoV-2 vaccine: a case report and review of the literature.
    Takedani K; Notsu M; Ishiai N; Asami Y; Uchida K; Kanasaki K
    BMC Endocr Disord; 2023 Jun; 23(1):132. PubMed ID: 37316819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential relationships between COVID-19 and the thyroid gland: an update.
    Naguib R
    J Int Med Res; 2022 Feb; 50(2):3000605221082898. PubMed ID: 35226548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graves' Disease Exacerbation with Impending Thyroid Storm After SARS-CoV-2 Infection: A Case Report.
    Sebastian WP; Parisa A; Pandya M; Anees A
    Am J Case Rep; 2024 Jan; 25():e941311. PubMed ID: 38184779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA typing of patients who developed subacute thyroiditis and Graves' disease after SARS-CoV-2 vaccination: a case report.
    Yasuda S; Suzuki S; Yanagisawa S; Morita H; Haisa A; Satomura A; Nakajima R; Oikawa Y; Inoue I; Shimada A
    BMC Endocr Disord; 2023 Mar; 23(1):54. PubMed ID: 36879263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four cases of Graves' disease following viral vector severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) vaccine.
    Chaudhary S; Dogra V; Walia R
    Endocr J; 2022 Dec; 69(12):1431-1435. PubMed ID: 35979558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion.
    Pla Peris B; Merchante Alfaro AÁ; Maravall Royo FJ; Abellán Galiana P; Pérez Naranjo S; González Boillos M
    J Endocrinol Invest; 2022 May; 45(5):1071-1077. PubMed ID: 35015288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves' disease.
    Murugan AK; Alzahrani AS
    Endocrine; 2021 Aug; 73(2):243-254. PubMed ID: 34106438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management.
    Caron P
    Endocrine; 2022 Dec; 78(3):406-417. PubMed ID: 35763241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graves' orbitopathy post-SARS-CoV-2 vaccines: report on six patients.
    Abeillon-du Payrat J; Grunenwald S; Gall E; Ladsous M; Raingeard I; Caron P
    J Endocrinol Invest; 2023 Mar; 46(3):617-627. PubMed ID: 36378488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-Induced Graves' Disease.
    Ghareebian H; Mariash C
    Cureus; 2022 Feb; 14(2):e22260. PubMed ID: 35340481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid storm after coronavirus disease 2019 mRNA vaccination in a patient with a history of Graves' disease after coronavirus disease 2019 infection.
    Saito M; Iijima T; Kurai H; Aso Y
    BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38834307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of Thyroid Dysfunction Due to COVID-19.
    Arefzadeh A
    Mini Rev Med Chem; 2024; 24(3):265-271. PubMed ID: 37069724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 vaccine may trigger thyroid autoimmunity: real-life experience and review of the literature.
    Ruggeri RM; Giovanellla L; Campennì A
    J Endocrinol Invest; 2022 Dec; 45(12):2283-2289. PubMed ID: 35829989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid disorders and SARS-CoV-2 infection: From pathophysiological mechanism to patient management.
    Caron P
    Ann Endocrinol (Paris); 2020 Oct; 81(5):507-510. PubMed ID: 32950466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-induced thyroid autoimmunity.
    Brancatella A; Viola N; Santini F; Latrofa F
    Best Pract Res Clin Endocrinol Metab; 2023 Mar; 37(2):101742. PubMed ID: 36813660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid Inflammation and Immunity During the COVID-19 Pandemic: A Comprehensive Review and Case Study.
    Lampropoulou E; Benz C; Kahaly GJ; Führer D
    Horm Metab Res; 2024 Feb; 56(2):111-117. PubMed ID: 38049146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases.
    Murugan AK; Alzahrani AS
    J Inflamm Res; 2021; 14():6191-6221. PubMed ID: 34853527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased incidence of Graves' disease during the SARS-CoV2 pandemic.
    Barajas Galindo DE; Ramos Bachiller B; González Roza L; García Ruiz de Morales JM; Sánchez Lasheras F; González Arnáiz E; Ariadel Cobo D; Ballesteros Pomar MD; Rodríguez IC
    Clin Endocrinol (Oxf); 2023 May; 98(5):730-737. PubMed ID: 36510647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.